It is additionally accredited for Older people who will be overweight with one or more weight-similar situations, which include substantial blood pressure level or Style 2 diabetes (substantial blood sugar). In March of 2024, the FDA accepted an extra indication for Wegovy—to reduce the risk of cardiovascular Dying, heart assault, https://glp-1weightlossmed.com/product/wegovy/